Short Interest in Nephros Inc. (NASDAQ:NEPH) Drops By 57.8%

Nephros Inc. (NASDAQ:NEPH) was the target of a large decline in short interest during the month of February. As of February 27th, there was short interest totaling 4,205 shares, a decline of 57.8% from the February 12th total of 9,959 shares. Based on an average daily volume of 46,029 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the company are short sold. Currently, 0.0% of the shares of the company are short sold. Based on an average daily volume of 46,029 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “hold (c)” rating on shares of Nephros in a research note on Thursday, January 22nd. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Nephros presently has an average rating of “Moderate Buy” and an average target price of $6.00.

Institutional Investors Weigh In On Nephros

A number of institutional investors and hedge funds have recently made changes to their positions in NEPH. Kestra Advisory Services LLC purchased a new position in shares of Nephros during the fourth quarter worth about $29,000. Dimensional Fund Advisors LP purchased a new stake in Nephros during the 3rd quarter valued at approximately $64,000. Heron Bay Capital Management purchased a new stake in Nephros during the 4th quarter valued at approximately $66,000. Citadel Advisors LLC lifted its position in Nephros by 39.2% during the 3rd quarter. Citadel Advisors LLC now owns 16,545 shares of the company’s stock worth $78,000 after acquiring an additional 4,655 shares during the period. Finally, XTX Topco Ltd grew its stake in shares of Nephros by 48.5% in the 4th quarter. XTX Topco Ltd now owns 21,617 shares of the company’s stock valued at $105,000 after purchasing an additional 7,062 shares during the last quarter. 41.10% of the stock is owned by hedge funds and other institutional investors.

Nephros Price Performance

NEPH stock opened at $4.09 on Wednesday. The company has a fifty day moving average price of $4.30 and a 200 day moving average price of $4.65. Nephros has a 12 month low of $1.49 and a 12 month high of $6.42. The company has a market cap of $43.48 million, a price-to-earnings ratio of 31.46 and a beta of 1.42.

About Nephros

Nephros, Inc is a development-stage company specializing in advanced water filtration and purification technologies for medical, laboratory, industrial and defense applications. The company’s core offering centers on proprietary hollow fiber ultrafilters designed to remove bacteria, viruses, endotoxins and particulates from water streams. These ultrafilters are used in hemodialysis systems to protect patient treatment, in pharmaceutical and laboratory environments to ensure water quality and in critical field-deployable units for military and emergency response.

The company’s product portfolio includes standalone filtration cartridges for point-of-use and point-of-entry installations in dialysis clinics and hospitals, as well as bench-top and portable water purification systems.